Patent No.: US7867522B2 Issued: 11/Jan/2011
Title: Method of wound/burn healing using copper-zinc compositions
Applicant/Assignee: JR CHEM, LLC
Application No.: 11/648278 Filing Date: 29/Dec/2006
Composition and methods for alleviating or eliminating wounds and/burns by providing an effective amount of one or more copper, zinc and copper-zinc compositions are disclosed. Treatment is accomplished through the use of topical compositions containing one or more copper or zinc salts and/or copper-zinc compounds or complexes, particularly copper-zinc malonate active ingredient.
Priority: US20060848616P Applic. Date: 2006-09-28
Inventor: FARYNIARZ JOSEPH R [US]; RAMIREZ JOSE E [US]
Patent No.: US7867527B2 Issued: 11/Jan/2011
Title: Skin Lightening Compositions Comprising Goya (Momordica Charantia) and Pine Extract
Applicant/Assignee: CONOPCO, INC
Application No.: 11/547553 Filing Date: 18/Feb/2005
A skin lightening composition comprising Goya or an extract thereof, and pine bark extract.
Priority: EP20040251836 Applic. Date: 2004-03-29; WO2005EP01821 Applic. Date: 2005-02-18
Inventor: CHARLES NEE NEWSHAM REBECCA LOUISE [GB]; YATES PAULA RACHEL [GB]
Patent No.: US7872047B2 Issued: 18/Jan/2011
Title: ESTERS OF LONG-CHAIN ALCOHOLS AND PREPARATION THEREOF
Applicant/Assignee: EASTMAN CHEMICAL COMPANY
Application No.: 12/028240 Filing Date: 08/Feb/2008
Disclosed is a composition and methods of treating a skin condition. The ester includes an ester and a dermatologically acceptable carrier. The ester is represented by the general formula 1:
Inventor: CLENDENNEN STEPHANIE KAY [US]; BOAZ NEIL WARREN [US]
Patent No.: US7879344B2 Issued: 01/Feb/2011
Title: Transdermal Delivery of Oleocanthal for Relief of Inflammation
Applicant/Assignee: KIMBERLY-CLARK WORLDWIDE, INC
Application No.: 11/427663 Filing Date: 29/Jun/2006
The present disclosure generally relates to compositions for reducing inflammation, and more particularly, to compositions comprising oleocanthal. The oleocanthal-containing compositions are particularly suitable for transdermal delivery. The compositions may also be used in combination with personal care products, such as wipes and absorbent articles, and may be incorporated into transdermal patches.
Inventor: FELDKAMP JOSEPH R [US]; KOENIG DAVID WILLIAM [US]; WENZEL SCOTT W [US]; JOSEPH WAEL [US]
Patent No.: US7888315B2 Issued: 15/Feb/2011
Title: USE OF ASPARTIC PROTEASES IN COSMETICS AND THERAPEUTICS
Application No.: 12/369228 Filing Date: 11/Feb/2009
The invention provides a cosmetic or pharmaceutical composition comprising, in a physiologically acceptable medium, at least one purified natural or synthetic polypeptide wherein the peptide sequence is represented wholly or partly by at least one sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 16, SEQ ID NO: 25 and SEQ ID NO: 27 and their homologs.
Priority: FR20020008613 Applic. Date: 2002-07-09; US2005-520521 Applic. Date: 2005-11-15; WO2003FR02151 Applic. Date: 2003-07-09
Inventor: BERNARD DOMINIQUE [FR]; MEHUL BRUNO [FR]
Patent No.: US7927614B2 Issued: 19/Apr/2011
Title: Anti-aging treatment using copper and zinc compositions
Applicant/Assignee: JR CHEM, LLC
Application No.: 11/452642 Filing Date: 14/Jun/2006
Composition and methods for alleviating or eliminating age related skin conditions by providing an effective amount of one or more copper, zinc and copper-zinc compositions are disclosed. Treatment is accomplished through the use of topical compositions containing one or more copper or zinc salts and/or copper-zinc compounds or complexes, particularly copper-zinc malonate active ingredient.
Priority: US20060764967P Applic. Date: 2006-02-03
Inventor: FARYNIARZ JOSEPH R [US]; RAMIREZ JOSE E [US]
Patent No.: US7943120B2 Issued: 17/May/2011
Title: Olefin wax, silicone-modified olefin wax, silicone-modified room temperature-solidifying composition using the wax, and cosmetics using them
Applicant/Assignee: MITSUI CHEMICALS, INC, SHIN-ETSU CHEMICAL CO., LTD
Application No.: 12/292724 Filing Date: 25/Nov/2008
An olefin wax (A) is (i) a copolymer (A1) obtained by copolymerizing ethylene and at least one diene or a copolymer (A2) obtained by copolymerizing ethylene, at least one olefin selected from [alpha]-olefins of 3 to 12 carbon atoms and at least one diene
wherein (ii) the content of unsaturated groups per one molecule is in the range of 0.5 to 3.0 groups
(iii) the density is in the range of 870 to 980 kg/m3
(iv) the melting point is in the range of 70 to 130 DEG C.
(v) the number-average molecular weight is in the range of 400 to 5,000
and (vi) the ratio (Mw/Mn) of the weight-average molecular weight to the number-average molecular weight is not more than 4.0. A silicone-modified olefin wax can be obtained by reacting hydrogen silicone with the olefin wax (A). Cosmetics contain the silicone-modified olefin wax.
Priority: JP20020302202 Applic. Date: 2002-10-16; US2005-531377 Applic. Date: 2005-09-26; WO2003JP13265 Applic. Date: 2003-10-16
Inventor: TOYODA HIDEO [JP]; UOSAKI HIROTAKA [JP]; KAN KOUJIRO [JP]; ICHINOHE SHOJI [JP]; SHIMIZU TORU [JP]
Patent No.: US7951888B2 Issued: 31/May/2011
Title: BLOCK COPOLYMER, COMPOSITION COMPRISING IT AND COSMETIC TREATMENT PROCESS
Applicant/Assignee: L'OREAL S.A, ARKEMA FRANCE
Application No.: 12/612554 Filing Date: 04/Nov/2009
The present invention relates to a linear ethylenic block copolymer comprising in each block at least one ionic hydrophilic unit, which may be different from one block to another, the said ionic hydrophilic unit being present in each block in a proportion of from 2% to 100% by weight relative to the weight of the said block. The invention also relates to a cosmetic or pharmaceutical composition comprising such a copolymer, and also to a cosmetic process for making up or caring for keratin materials using the said composition.
Priority: FR20040050718 Applic. Date: 2004-04-09; US2005-101648 Applic. Date: 2005-04-08; US20040562255P Applic. Date: 2004-04-15
Inventor: BOUPAT NICOLAS PASSADE [FR]; GUERRET OLIVIER [FR]; MOUGIN NATHALIE [FR]; SCHULTZE XAVIER [FR]; HERNANDEZ FRANCK [FR]
Patent No.: US7964188B2 Issued: 21/Jun/2011
Title: Use of placental alkaline phosphatase to promote skin cell proliferation
Applicant/Assignee: ESSENTIAL SKINCARE, LLC
Application No.: 11/528172 Filing Date: 27/Sep/2006
Methods for promoting survival and stimulating proliferation of cells in the epidermis and dermis of undamaged mammalian skin are disclosed. The methods comprise the step of administering to an area of the skin a composition comprising a therapeutically effective amount of human placental alkaline phosphatase, or an active derivative. The composition can be administered topically or by injection. Embodiments of the invention also provide regimens for restoring or maintaining the strength and thickness of aging skin, comprising periodically administering a composition by topical application. Other embodiments of the invention further provide methods for promoting survival and stimulating proliferation of cells in the epidermis and dermis of transplanted skin. A composition for topical application is also provided by some embodiments of the invention.
Priority: US2003-653622 Applic. Date: 2003-09-02
Inventor: KISS ZOLTAN [US]
Patent No.: US7968113B2 Issued: 28/Jun/2011
Title: Liquid bandages
Applicant/Assignee: BIOMEDICAL DEVELOPMENT CORP
Application No.: 12/011879 Filing Date: 30/Jan/2008
A method is provided to treat skin to restore barrier homeostasis and to promote normal stratum corneum function by applying to the skin a liquid composition which forms a phase inversion membrane. The amount of solids in the liquid composition is varied so as to provide a desired degree of porosity to the resulting membrane.
Inventor: SIEGEL GREGG [US]
Patent No.: US7976832B2 Issued: 12/Jul/2011
Title: Active topical skin protectants containing amines, polyalkenimines and /or derivatives
Applicant/Assignee: THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY
Application No.: 10/429431 Filing Date: 05/May/2003
A topical skin protectant formulation containing a barrier cream and an active moiety for protecting warfighters and civilians against all types of harmful chemicals, specifically chemical warfare agents (CWA). The active moiety is an amine, polyalkenimines and/or derivatives. The topical skin protectant offers a barrier property and an active moiety that serves to neutralize chemical warfare agents into less toxic agents.
Priority: US20020378443P Applic. Date: 2002-05-06
Inventor: BRAUE JR ERNEST H [US]; HOBSON STEPHEN T [US]; BOECKER JOSEPH D [US]; SMITH BRYAN M [US]
Patent No.: US7985424B2 Issued: 26/Jul/2011
Title: Dendritic Polymers With Enhanced Amplification and Interior Functionality
Applicant/Assignee: DENDRITIC NANOTECHNOLOGIES, INC, DENDRITIC NANOTECHNOLOGIES INC
Application No.: 11/630044 Filing Date: 21/Dec/2005
Dendritic polymers with enhanced amplification and interior functionality are disclosed. These dendritic polymers are made by use of fast, reactive ring-opening chemistry (or other fast reactions) combined with the use of branch cell reagents in a controlled way to rapidly and precisely build dendritic structures, generation by generation, with cleaner chemistry, often single products, lower excesses of reagents, lower levels of dilution, higher capacity method, more easily scaled to commercial dimensions, new ranges of materials, and lower cost. The dendritic compositions prepared have novel internal functionality, greater stability (e.g., thermal stability and less or no reverse Michael's reaction), and reach encapsulation surface densities at lower generations.
Unexpectedly, these reactions of polyfunctional branch cell reagents with polyfunctional cores do not create cross-linked materials. Such dendritic polymers are useful as demulsifiers for oil/water emulsions, wet strength agents in the manufacture of paper, proton scavengers, polymers, nanoscale monomers, calibration standards for electron microscopy, making size selective membranes, and agents for modifying viscosity in aqueous formulations such as paint. When these dendritic polymers have a carried material associated with their surface and/or interior, then these dendritic polymers have additional properties for carrying materials due to the unique characteristics of the dendritic polymer, such as for drug delivery, transfection, and diagnostics.
Priority: WO2005US13864 Applic. Date: 2005-04-20; US20040563659P Applic. Date: 2004-04-20; WO2005US47635 Applic. Date: 2005-12-21
Inventor: TOMALIA DONALD A [US]; SWANSON DOUGLAS R [US]; HUANG BAOHUA [US]; PULGAM VEERA REDDY [US]; HEINZELMANN JOSEPH R [US]; SVENSON SONKE [US]; REYNA LORI A [US]; ZHURAVEL MICHAEL A [US]; CHAUHAN ABHAY SINGH [US]; DEMATTEI CORDELL R [US]
Patent No.: US7993630B2 Issued: 09/Aug/2011
Title: Protection of Skin from UV and Peroxide
Applicant/Assignee: BIODERM RESEARCH
Application No.: 12/497662 Filing Date: 04/Jul/2009
The present invention discloses certain heterocyclic complexes of metals of formula (I), especially those of manganese, which enhance the safety and efficacy of sunscreens via urocanate pathway modulation. The present invention also discloses a method for topical application of said complexes, which causes the reduction of topical peroxide including hydrogen peroxide, the reduction of topical inflammation including sunburn, increased sun protection of skin, comprehensive protection from UVA, UVB, and UVC, reduction of radiation-initiated inflammation, the reduction of skin wrinkles, acne, and overall treatment of skin damaged from natural aging and exposure to sun:
Priority: US2007-676284 Applic. Date: 2007-02-17
Inventor: GUPTA SHYAM K [US]
Patent No.: US7993661B2 Issued: 09/Aug/2011
Title: Skin make-up composition comprising a resin
Application No.: 11/484625 Filing Date: 12/Jul/2006
The present invention relates to a skin make-up or care composition containing a liquid fatty phase having at least one resin having a number-average molecular weight of less than or equal to 10 000 g/mol, chosen from rosin, rosin derivatives, hydrocarbon-based resins, and mixtures thereof. The invention also relates to a non-therapeutic use of the invention composition in a process for making up or caring for the skin and for obtaining a deposit on the skin which has good transfer resistance, in particular in the presence of sebum.
Priority: US20050698884P Applic. Date: 2005-07-13
Inventor: ARNAUD PASCAL [FR]; LU SHAOXIANG [US]
Patent No.: US7998467B2 Issued: 16/Aug/2011
Title: Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers
Applicant/Assignee: GALDERMA RESEARCH & DEVELOPMENT
Application No.: 12/076169 Filing Date: 14/Mar/2008
Cosmetic/dermatological compositions for topical application and useful for the treatment, e.g., of acne, contain, formulated into a physiologically acceptable medium, at least one naphthoic acid compound and at least one polyurethane polymer or derivative thereof, the at least one naphthoic acid compound being dispersed therein.
Priority: FR20050009493 Applic. Date: 2005-09-16; WO2006IB03852 Applic. Date: 2006-09-15
Inventor: MALLARD CLAIRE [FR]; FERRARA EVE [FR]
Patent No.: US7998493B2 Issued: 16/Aug/2011
Title: Cosmetic or dermopharmaceutical compositions which are used to reduce bags and circles under the eyes
Applicant/Assignee: SEDERMA SAS
Application No.: 10/504643 Filing Date: 25/Feb/2005
The invention relates to novel cosmetic or dermopharmaceutical compositions for topical use which are used to prevent the symptoms of cutaneous slackening and, more specifically, to treat the visible signs of ageing and fatigue, such as bags and circles under the eyes. The inventive compositions comprise, in a cosmetically-acceptable medium, a combination of at least two, and preferably three, components selected from: a) hesperidin or the derivatives thereof
b) A.C.E. enzyme inhibitor dipeptides
and c) oligopeptides R2-(AA)n-Pro-Arg, wherein (AA)n is a peptide chain, (AA) is any amino acid or any derivative of any amino acid, n is included between 1 and 3, and R2-H or an alkoyl chain having a carbon length of between C2 and C22.
Priority: FR20020001967 Applic. Date: 2002-02-15; WO2003FR00441 Applic. Date: 2003-02-10
Inventor: LINTNER KARL [FR]
Patent No.: US8003082B2 Issued: 23/Aug/2011
Title: Photostable organic sunscreen composition
Applicant/Assignee: MERCK PATENT GMBH
Application No.: 10/559291 Filing Date: 27/May/2004
The present invention relates to a sunscreen capsule comprising i) at least one UV-A organic sunscreen and ii) at least one photostabilizer, furthermore it relates to a composition for topical application comprising these capsule and methods of production and use of these capsules and compositions.
Priority: US2003-452199 Applic. Date: 2003-06-03; WO2004EP05716 Applic. Date: 2004-05-27
Inventor: CHAUDHURI RATAN [US]
Patent No.: US8022179B2 Issued: 20/Sep/2011
Title: Compositions and methods for topical application and transdermal delivery of an oligopeptide
Applicant/Assignee: REVANCE THERAPEUTICS, INC
Application No.: 11/368198 Filing Date: 03/Mar/2006
The invention relates to the transdermal application of oligopeptides for reducing synaptic transmission in tissues of an animal. In one aspect, this invention relates to compositions comprising an oligopeptide and optionally a carrier comprising a positively charged "backbone" having positively charged branching or "efficiency" groups, as described herein. Most preferably the positively charged carrier is a long-chain positively charged polypeptide or a positively charged nonpeptidyl polymer, for example, a polyalkyleneimine. The invention further relates methods for producing a biologic effect of reducing synaptic transmission in a tissue by topically applying an effective amount of such a composition, preferably to the skin, of a subject or patient in need of such treatment.
This invention also provides kits for preparing or formulating a composition that comprises the oligopeptide and optionally a carrier, as well as such additional items that are needed to produce a usable formulation, or a premix that may in turn be used to produce such a formulation.
Priority: US20050658741P Applic. Date: 2005-03-03
Inventor: DAKE MICHAEL D [US]; WAUGH JACOB M [US]
Patent No.: US8029810B2 Issued: 04/Oct/2011
Title: Water-based delivery systems
Application No.: 12/290455 Filing Date: 30/Oct/2008
The invention relates to a water-based delivery system for an active substance, characterized by enhancing skin barrier restoration in the stratum corneum comprising water, a fatty acid, cholesterol, a ceramide and at least one skin lipid precursor.
Priority: US2004-957320 Applic. Date: 2004-09-30; US2003-388371 Applic. Date: 2003-03-13; WO2003US07752 Applic. Date: 2003-03-13; US20020365059P Applic. Date: 2002-03-13
Inventor: SKOLD THOMAS [SE]
Patent No.: US8029812B2 Issued: 04/Oct/2011
Title: PERSONAL CARE COMPOSITIONS
Applicant/Assignee: E. I. DU PONT DE NEMOURS AND COMPANY
Application No.: 12/400309 Filing Date: 09/Mar/2009
This invention relates to personal care compositions containing polytrimethylene ether glycol in a variety of physical forms including solutions, gels, oil-in-water emulsions, water-in-oil emulsions, suspensions and solids. In a particularly preferred embodiment, the polytrimethylene ether glycol is derived predominantly from monomers obtained from renewable resources, making the personal care products of this embodiment of the present invention more environmentally friendly in terms of their manufacture, use and disposal.
Priority: US2007-801872 Applic. Date: 2007-05-11; US20060801166P Applic. Date: 2006-05-17
Inventor: SUNKARA HARI BABU [US]
Patent No.: US8053427B1 Issued: 08/Nov/2011
Title: Brimonidine gel composition
Applicant/Assignee: GALDERMA R&D SNC
Application No.: 13/158987 Filing Date: 13/Jun/2011
Improved topical gel compositions, such as those containing brimonidine, for the treatment of skin disorders are described. The gel compositions contain carbomer and methylparaben, and are substantially free of methylparaben crystalline particles after an extended period of storage.
Priority: US20100405388P Applic. Date: 2010-10-21
Inventor: BUGE JEAN-CHRISTOPHE [FR]; NADAU-FOURCADE KARINE [FR]; MEUNIER CYRIL [FR]
Patent No.: US8063097B2 Issued: 22/Nov/2011
Title: Compositions and methods for regulating mammalian keratinous tissue
Applicant/Assignee: THE PROCTER & GAMBLE COMPANY
Application No.: 11/891860 Filing Date: 14/Aug/2007
Skin care compositions and methods for regulating the condition of mammalian keratinous tissue containing an effective amount of a dipalmitoyl hydroxyproline salt and a second skin care compound selected from hexamidine compounds, sugar amine compounds and their combination.
Priority: US2003-418594 Applic. Date: 2003-04-17
Inventor: ROBINSON LARRY RICHARD [US]; TANNER PAUL ROBERT [US]
Patent No.: US8071114B2 Issued: 06/Dec/2011
Title: Compositions containing quaternary ammonium compounds
Applicant/Assignee: NOVAGALI PHARMA SA, NOVAGLI PHARMA S.A
Application No.: 11/822603 Filing Date: 09/Jul/2007
This invention relates to compositions containing quaternary ammonium compounds in which the nitrogen atom is substituted by at least one alkyl group having at least 12 carbon atoms, characterized in that said composition includes at least 20% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 14 carbon atoms and more than 5%, preferably more than 7% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 16 carbon atoms. This invention also relates to ophthalmic oil-in-water emulsions containing such compositions, said ophthalmic emulsions being useful for eye care or for the treatment of eye conditions.
Priority: EP20060291236 Applic. Date: 2006-07-28; US2006-494493 Applic. Date: 2006-07-28
Inventor: RABINOVICH-GUILATT LAURA [FR]; LAMBERT GREGORY [FR]; LALLEMAND FREDERIC [FR]; PHILIPS BETTY [FR]